Zafirlukast
Product Images NDC 68151-1977

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Zafirlukast (NDC 68151-1977). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton10mg (Carton10mg)

Packaging label for Zafirlukast Tablets 10 mg by Dr. Reddy's Laboratories Limited. The label includes dosage instructions, warnings to keep out of reach of children, storage conditions, and specifies a package size of 100 tablets (10 x 10 unit-dose). The label notes it is for institutional use only and provides manufacturer details from Bachepalli, India.*

FDA Label Image

Carton20mg (Carton20mg)

Packaging label for Zafirlukast Tablets 20 mg by Dr. Reddy's Laboratories Limited. The label shows the product name, dosage strength, tablet form, and NDC 55111-626-78. It includes storage instructions, warnings, and a note of institutional use with a package count of 100 tablets in 10 blister cards of 10 unit-dose tablets each.*

FDA Label Image

Container20mg (Container20mg)

Zafirlukast Tablets 20 mg bottle label from Dr. Reddy's Laboratories. The label indicates 100 tablets per container, prescription only. Storage instructions specify 20º-25ºC temperature and protection from light and moisture. It also includes child safety dispensing and dosage information.*

FDA Label Image

Container10mg30 (Container10mg30)

Zafirlukast 10 mg tablets packaging label from Carilion Materials Management. The label indicates a 30-tablet count in the original airtight container and includes storage instructions to keep the product between 20°C to 25°C (68°F to 77°F) in a tightly closed container, protected from light and moisture. The label also displays the NDC number 55111-625-30 and contains dispensing and warning information.*

FDA Label Image

Container20mg30 (Container20mg30)

Label for Zafirlukast Tablets 20 mg, containing 30 tablets. The label indicates prescription use only and advises dispensing in the original airtight container. It includes storage instructions to keep the tablets between 20°-25°C (68°-77°F), away from moisture, and prompts users to protect from light and moisture. The label bears the product NDC 55111-626-30 and manufacturer information for Dr. Reddy's Laboratories Limited.*

FDA Label Image

Graph (Graph)

A line graph titled 'Mean β2 - agonist use (puffs/day)' illustrating adjusted treatment means of β2-agonist use over 14 trial weeks. The graph compares three groups: Placebo, Zafirlukast 20 mg twice daily, and Cromolyn sodium 1600 mcg four times a day. The y-axis shows puffs per day ranging from 2 to 6, and the x-axis represents trial weeks from 0 to 14.*

FDA Label Image

Lbl681511977

Zafirlukast 20 mg tablet label showing the brand name, strength, dosage form, manufacturer as Dr. Reddy's, lot number C304401, expiration date 07/14, and a barcode with associated NDC 68151-1977. The label states 'Rx only.'*

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredient Zafirlukast as shown in the image, depicting the molecular arrangement with labeled atoms and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.